Dr Reddy's Labs may face an 8-12 month delay in launching its semaglutide generic in Canada after receiving a non-compliance ...

Zydus Lifesciences Ltd and Torrent Pharmaceuticals Ltd are preparing to enter the fast-growing market for Semaglutide — a ...

Decision is a setback for Dr. Reddy’s Laboratories, which was poised to be one of the first generic competitors to Ozempic ...

Ramesh Swaminathan, Executive Director and CFO of Lupin, says India’s weight-loss drug market could reach $1 billion, and ...

Dr. Reddy's Semaglutide weight-loss drug launch in Canada faces delays due to regulatory compliance issues, impacting share ...

New versions of drugs like Wegovy, Ozempic, Mounjaro and Zepbound, including pills, will be easier to take, more effective ...

Three new Cochrane reviews find evidence that GLP-1 drugs lead to clinically meaningful weight loss, though industry-funded ...

A new deal with major drugmakers, unveiled by U.S. President Donald Trump on Thursday, aims to expand coverage and cut prices ...

Obesity products gain momentum in India and globally as multinationals leverage smart pricing and collaborations amidst ...

The number of medications in development to treat obesity continues to grow, and the drugs can offer health benefits for ...

Shares of Dr. Reddy's Laboratories and Shaily Engineering Plastics slumped after the drug major informed the exchanges about a delay in approval for its Semaglutide injection in the Canadian market.

Middle-class Indians trying to lose weight are embracing drugs such as Mounjaro, which is also used to treat diabetes in a ...